Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609

Watchlist Manager
Shanghai HeartCare Medical Technology Corp Ltd Logo
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
Watchlist
Price: 24 HKD 7.62% Market Closed
Market Cap: 932m HKD
Have any thoughts about
Shanghai HeartCare Medical Technology Corp Ltd?
Write Note

Operating Margin
Shanghai HeartCare Medical Technology Corp Ltd

-24.4%
Current
-93%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-24.4%
=
Operating Profit
-61.3m
/
Revenue
251.2m

Operating Margin Across Competitors

Country CN
Market Cap 866m HKD
Operating Margin
-24%
Country US
Market Cap 205.2B USD
Operating Margin
17%
Country US
Market Cap 193.1B USD
Operating Margin
26%
Country US
Market Cap 148.6B USD
Operating Margin
22%
Country US
Market Cap 132.9B USD
Operating Margin
18%
Country IE
Market Cap 109.9B USD
Operating Margin
19%
Country US
Market Cap 64.8B USD
Operating Margin
14%
Country DE
Market Cap 56.6B EUR
Operating Margin
12%
Country CN
Market Cap 326.2B CNY
Operating Margin
36%
Country US
Market Cap 42.2B USD
Operating Margin
28%
Country US
Market Cap 37.7B USD
Operating Margin
13%
No Stocks Found

Shanghai HeartCare Medical Technology Corp Ltd
Glance View

Market Cap
932m HKD
Industry
Health Care

Shanghai Heartcare Medical Technology Corp. Ltd. engages in the research, development, manufacture, and sale of neuro-interventional medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-08-20. The firm's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The firm's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The firm's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The firm distributes its products within the domestic market.

Intrinsic Value
34.43 HKD
Undervaluation 30%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-24.4%
=
Operating Profit
-61.3m
/
Revenue
251.2m
What is the Operating Margin of Shanghai HeartCare Medical Technology Corp Ltd?

Based on Shanghai HeartCare Medical Technology Corp Ltd's most recent financial statements, the company has Operating Margin of -24.4%.